Biopharma exec says Bitcoin could help industry through ‘biotech winter’
Holding Bitcoin could help biotech firms survive the long period of time it takes to bring products to market, says Atai Life ...
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...
Xortx Therapeutics to provide Type B meeting package to FDA during next week
XORTX Therapeutics (XRTX) provided an update regarding communications with the US Food and Drug Administration. At the request of the FDA a ...
Fierce Biotech2d
Roche continues ADC dealmaking spree with $1B biobucks pact with Oxford BioTherapeutics
Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...
A cell pulls off one of the 'Holy Grails' of biotechnology
A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...
Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding Burden
Nanobiotix amended its $2.7 billion licensing deal with Johnson & Johnson, reducing costs while retaining key milestone payments. The update extends its cash runway to mid-2026.
Exelixis, Inc. (EXEL): Among the Best Biotech Stocks to Buy According to Billionaires
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Exelixis, Inc.
Local biotech company rebrands as Longevity Health Holdings
South Side-based biotech firm Carmell Corp. announced a comprehensive corporate rebrand and will now operate under the new ...
Australia's PolyNovo chief steps down after reports of rift with chair
Australian biotech company PolyNovo said on Tuesday it has removed its CEO after discussions with the executive last week following media allegations about bullying by the firm's chairman directed at ...
KAAL TV10d
US biochemist researching treatment of HIV and coronaviruses wins Israel’s Wolf Prize
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
‘Startup Nation’ Groups Say They’re Meeting Trump Officials to Push for Deregulated ‘Freedom Cities’
The architects of projects like Próspera are drafting legislation to create US cities that would be free from federal ...
I-Mab Biopharma: I-Mab Announces Accelerated Givastomig Phase 1b Study Progress
Enrollment completed ahead of schedule in the first dose expansion cohortMomentum continues with first patient dosed in the second expansion cohortTopline results from the 40-patient dose expansion st ...